about
Phase I clinical trial of lenalidomide in combination with sorafenib in patients with advanced cancer.Phase I clinical trial of lenalidomide in combination with temsirolimus in patients with advanced cancer.Chronic Myeloid Leukemia in India.A rare case of peripheral T-cell lymphoma in 1-year-old child.First report of upfront treatment with Gefitinib in comparison with chemotherapy in advanced non-small cell lung cancer patients from south India: Analysis of 120 patients.Solid variant of alveolar rhabdomyosarcoma mimicking non-Hodgkin lymphoma: case report and review of literature.Report of chronic myeloid leukemia in chronic phase from Cancer Institute (Women India Association), Chennai, 2002-2009.Leukemic infiltration of lung mimicking fungal pneumonia.Adrenal metastases in a post-radiation malignant fibrous histiocytoma after low-dose radiation for a benign conditionNonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia.Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge and Response to Aminophylline.Treatment of chronic phase chronic myeloid leukemia with imatinib.Early onset sinonasal mucormycosis during induction therapy of acute lymphoblastic leukemia: good outcome without surgical intervention.Effectiveness of olanzapine in patients who fail therapy with aprepitant while receiving highly emetogenic chemotherapy.Hodgkin's lymphoma--long-term outcome: an experience from a tertiary care cancer center in North India.Acute myeloid leukemia mimicking parotid tumor: importance of peripheral smear.Anaplastic large cell lymphoma: association with peripheral blood neutrophilia at presentation.Adult T-cell leukemia in India: report of two cases and review of literature.Refractory ALK-Positive Anaplastic Large Cell Lymphoma: Long Term Survival with CrizotinibSystemic hypertension due to compression of the kidney by a pancreatic pseudocystMIC-2 positive granulocytic sarcoma of ulna mimicking Ewing sarcomaMediastinal mass and paraparesis as the sole presenting features of Langerhans cell histiocytosisVoriconazole-induced pancreatitis in a patient of acute myeloid leukemia and invasive aspergillosisFavorable outcome in a patient with vulvar mucormycosis during acute myeloid leukemia induction with medical management aloneMultiple myeloma presenting as mediastinal massLiving with chronic myeloid leukemia in India-an exploratory studyInduction therapy for multiple myeloma: more is not necessarily better!A modified olanzapine-based anti-emetic regimen for the control of nausea and vomiting in patients receiving weekly cisplatinAcute Lymphoblastic Leukemia in Young Adults Treated with Intensive "Pediatric" Type ProtocolExperience with the Use of Nilotinib in Indian PatientsDA-EPOCH-R in Aggressive CD 20 Positive B Cell Lymphomas: Real-World ExperienceChronic Myeloid Leukemia: Long-Term Outcome Data in the Imatinib EraOutcomes of Oral Metronomic Therapy in Patients with LymphomasOutcomes of Intensive Treatment of Adult Acute Myeloid Leukemia Patients: A Retrospective Study From a Single Centre
P50
Q33408279-EB9F80A5-652B-4EFC-BD70-1EF655AD9578Q33410022-D4D15D50-4B0D-48B4-A1B5-C86B9CD0D43FQ33859551-62A55C2F-500D-43BD-962F-6B9287468AE7Q35931553-4B047B59-BD83-4524-A887-6AC1D4AF4B47Q36470136-DC1D89B2-BBA4-40FA-BEBD-4837A4804FAEQ37326262-32966A10-78EE-4793-B410-F7BF0AD0521EQ37517627-D214162A-131B-462A-8C9F-8FE2E05EC48EQ37578196-75C919D4-FAA8-461D-A83E-431A16C7F798Q38123479-5F2E5813-5E70-43B2-BBBC-0BF2D4EA57F9Q39754589-B1AD0E1B-487A-4BCF-934C-ECC11E2395C3Q42938463-3F98F26D-916D-4E64-B309-FD8C2D700108Q44774546-175D0E32-EDB1-494E-857F-D78316DD2F5EQ46133065-4A0AF280-9CE1-4993-BD8F-BE7A4A3CC4BCQ47296270-8C9663D3-AF90-47CC-8B4D-E25C09CD42F5Q51456724-6B171357-54AA-4B37-8908-E2A554B7D7DAQ53356298-883DE16C-61C3-4186-8C19-7D35060264FBQ54452896-316DF0DF-273A-4780-A8F9-A1372531E8FDQ55239237-9969B842-5485-47A7-A088-6B0B7BD36D83Q56524606-82EC6921-2DAB-408C-8BB7-EF69DC3E9D50Q81151563-9CB2740A-431C-4878-8B6A-7EECDE44A4CAQ81742342-C8AC288E-CF55-4452-A22E-BA1F8C98A017Q83180927-E69FC203-ADE8-4995-92E5-C9C7DE8688D7Q84411405-07E780A5-7400-40FF-85BB-EFD939A9BF17Q84612944-13C52FA2-BEB4-499E-A5B0-FAFAD2D75FFEQ87397623-3A729F76-7D9E-466F-ACF3-31F6AF486CE8Q87739684-398517E1-84CD-40E0-9727-4420FFD318B8Q88419608-CDA6868E-7089-4638-9847-FBE51BCD5688Q90173424-B4395C21-F604-4552-AE9D-D5C8641CD393Q91049534-9667AB0D-9873-4628-B9A0-5D1BF410EE64Q91049548-CDD727F8-A927-4D51-9024-BA9DE23D16FEQ91049557-F426CF6F-5A31-4EFC-B495-EBB93400087EQ92087023-6DBB79E5-9F5E-498F-9B70-8EE523E901BDQ92087037-AFB32ACE-4C7B-40BA-BC99-419922B0803CQ93112984-024475CD-8271-440E-ACAE-8EDEDEE866FD
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Prasanth Ganesan
@ast
Prasanth Ganesan
@en
Prasanth Ganesan
@es
Prasanth Ganesan
@nl
Prasanth Ganesan
@sl
type
label
Prasanth Ganesan
@ast
Prasanth Ganesan
@en
Prasanth Ganesan
@es
Prasanth Ganesan
@nl
Prasanth Ganesan
@sl
prefLabel
Prasanth Ganesan
@ast
Prasanth Ganesan
@en
Prasanth Ganesan
@es
Prasanth Ganesan
@nl
Prasanth Ganesan
@sl
P1053
H-1545-2013
P106
P31
P3829
P496
0000-0003-2762-6591
P569
2000-01-01T00:00:00Z